Which is the drug to treat NARST (Nalidixic acid resistant S.typhi)?
**Core Concept**
The treatment of nalidixic acid-resistant Salmonella Typhi requires a different class of antibiotics that can effectively target the resistant bacteria. This is a critical concept in the management of typhoid fever, especially in regions where antibiotic resistance is prevalent.
**Why the Correct Answer is Right**
The correct answer is a fluoroquinolone antibiotic, which is effective against a broad spectrum of bacteria, including nalidixic acid-resistant S. Typhi. Fluoroquinolones work by inhibiting DNA gyrase and topoisomerase IV, essential enzymes for bacterial DNA replication and transcription. This results in the accumulation of toxic DNA strands, ultimately leading to bacterial cell death.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it is an aminoglycoside antibiotic, which is not effective against S. Typhi and may not be suitable for treating typhoid fever.
**Option B:** This option is incorrect because it is a macrolide antibiotic, which may not be effective against S. Typhi and can be associated with gastrointestinal side effects.
**Option C:** This option is incorrect because it is a beta-lactam antibiotic, which may not be effective against S. Typhi and can be associated with resistance in some strains.
**Clinical Pearl / High-Yield Fact**
It's essential to note that the treatment of typhoid fever should be guided by local antibiotic resistance patterns and the patient's clinical response. Fluoroquinolones are generally effective against nalidixic acid-resistant S. Typhi, but other antibiotics, such as azithromycin or ceftriaxone, may also be considered in certain cases.
**Correct Answer:** C. Ciprofloxacin